follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Amicus Therapeutics appoints new CMO, COO

By

Back to Top Comments Email Print

Latest News

    advertisement

    Cranbury-based biopharmaceutical company Amicus Therapeutics Inc. announced Monday the appointment of Jay A. Barth as chief medical officer effective immediately.

    According to the announcement, the company also announced the promotion of Bradley L. Campbell from chief business officer to chief operating officer, effective Dec. 2013.

    Barth will be responsible for all clinical development activities as well as regulatory affairs.

    Campbell will head several departments including business development, program management, commercial planning, patient and professional advocacy, and technical operations.  He will also oversee preclinical research and development, the announcement said.

    ALSO ON NJBIZ:

    Barnabas to launch its own health insurance plan

    Five N.J. companies earn praise for working well with women-owned businesses

    Mack-Cali announces major leadership shakeup

    Share This Story On:
    Emily Bader

    Emily Bader

    Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top